Sep 9, 2026 05:40AM
Sep 8, 2026 08:04AM
Aug 27, 2026 02:20AM
Aug 26, 2026 07:28AM
Aug 25, 2026 04:49PM
Aug 4, 2026 05:51PM
Jul 28, 2026 05:35AM Wolfe Research Downgrades Spyre (SYRE) to Peerperform
Jul 13, 2026 06:46AM
Jun 26, 2026 04:09PM
Jun 18, 2026 04:00PM
Jun 15, 2026 08:01AM
Jun 4, 2026 04:10AM
Jun 3, 2026 08:03AM
May 5, 2026 04:26PM Spyre (SYRE) PT Raised to $107 at Stifel
May 5, 2026 10:20AM
Apr 13, 2026 04:21PM
Apr 13, 2026 03:10PM
Apr 13, 2026 02:39PM
Apr 13, 2026 12:37PM
Apr 13, 2026 11:24AM
Apr 13, 2026 10:38AM Spyre (SYRE) PT Raised to $80 at Wedbush
Apr 13, 2026 08:45AM
Apr 13, 2026 08:26AM
Apr 13, 2026 08:21AM
Apr 13, 2026 07:57AM
Apr 13, 2026 07:54AM
Apr 13, 2026 07:46AM
Apr 13, 2026 07:00AM Spyre reports positive trial results for ulcerative colitis drug SPY001
Apr 13, 2026 06:56AM
Mar 31, 2026 05:18AM
Mar 18, 2026 07:32AM
Mar 16, 2026 11:33AM
Mar 16, 2026 10:39AM
Feb 19, 2026 04:35PM
Jan 12, 2026 08:04AM Spyre Therapeutics expects six trial readouts in 2026
Dec 17, 2025 04:04PM
Dec 17, 2025 05:02AM
Dec 1, 2025 12:33AM
Nov 5, 2025 07:29AM
Nov 4, 2025 05:50PM
Oct 13, 2025 04:41PM
Oct 7, 2025 05:55AM Guggenheim Reiterates Buy Rating on Spyre (SYRE), 'remains one of our Top Picks'
Sep 26, 2025 03:27AM
Aug 18, 2025 06:13AM
Aug 6, 2025 03:16AM
Jun 17, 2025 07:30AM
Jun 4, 2025 06:23AM
Jun 3, 2025 06:20AM
May 8, 2025 04:17PM Spyre Therapeutics, Inc. (SYRE) Tops Q1 EPS by 24c
Mar 28, 2025 05:24AM

448,012 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All